Actionable news
0
All posts from Actionable news
Actionable news in PRGO: PERRIGO COMPANY PLC,

10 Stocks Moving In Monday's Pre-Market Session

Invest with Confidence. Are you a financial professional? Stay on top of your portfolio with Benzinga Pro's real-time newsfeed and alerts and never miss a headline again.
Don't miss the chance to try it FREE today.


Gainers

Tribune Publishing Co TPUB shares rose 60.90 percent to $12.10 in pre-market trading as Gannett Co Inc GCI offered to buy Tribune Publishing for $12.25 per share in cash.

Sarepta Therapeutics Inc SRPT shares rose 7.02 percent to $16.00 in pre-market trading after surging 35.66 percent on Friday.

Valeant Pharmaceuticals Intl Inc VRX rose 4.70 percent to $37.66 in pre-market trading after surging 7.86 percent on Friday.

Secureworks Corp SCWX rose 4.29 percent to $14.60 in pre-market trading. On Thursday, SecureWorks priced its 8 million share IPO at $14.00 per share.

Synergy Pharmaceuticals Inc SGYP shares rose 1.60 percent to $3.80 in pre-market trading after gaining 3.31 percent on Friday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

Perrigo Company plc Ordinary Shares PRGO shares fell 8.48 percent to $111.01 in pre-market trading as the company named John T. Hendrickson as its CEO. The company reported weak preliminary Q1 financial results, and also lowered its full year outlook.

Koninklijke Philips NV (ADR) PHG shares fell 5.20 percent to $26.81 in pre-market trading. Philips said it was likely to seek an IPO for its lighting unit.

Sohu.com Inc SOHU shares fell 3.48 percent to $46.05 in pre-market trading. Sohu.com posted a Q1 loss per share of $0.53 per share on revenue of $407.95 million.

Murphy Oil Corporation MUR shares fell 2.67 percent to $32.76 in pre-market trading after rising 6.39 percent on Friday.

General Motors Company GM shares fell 1.43 percent to $31.72 in pre-market trading after dropping 1.50 percent on Friday.

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.